Loading...
Loading...
In a report published Tuesday, Morgan Stanley analyst Bin Li reiterated an Underweight rating on
Concord Medical Services Holdings Ltd.CCM, but removed the $7.00 price target.
In the report, Morgan Stanley noted, “CCM's 3Q14 non-GAAP EPS of Rmb0.72 beat our estimate by 25%, mainly due to lower G&A expenses caused by the collection of bad debt. Management reiterated 2014 guidance of EPS of US$0.45-0.50 (+25-38% YoY), given the solid operation performance.”
Concord Medical Services Holdings Ltd. closed on Monday at $6.94.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in